Spanish researchers develop five-strain Ebola vaccine

July 11, 2018
Credit: CC0 Public Domain

Spanish researchers are working on a vaccine against all five strains of the killer Ebola virus in what would be a world first, Madrid's October 12 Hospital said Wednesday.

A prototype vaccine developed by pharmaceutical group Merck is already in use, but acts only against the most virulent, "Zaire" strain.

Despite not having market approval, Merck's rVSV-ZEBOV was administered to people in the Democratic Republic of Congo in May, with UN approval, in a bid to contain an outbreak of the same virus that killed more than 11,300 in three West African countries from 2013-2015, sparking international panic.

For several months, a team from the October 12 Hospital has been working with researchers at two other hospitals in the capital to examine and learn from blood samples taken from three people cured of Ebola in Spain.

Lead researcher Rafael Delgado told reporters the difficulty lay in the fact that the virus protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time.

That makes it tough for the body's immune system to fight the .

The three Spanish patients had produced "very effective" viral antibodies, though in a "small quantity" and only against the Zaire strain they were contaminated with.

Delgado, head of microbiology at the , said researchers are aiming to reproduce these antibodies on a larger scale, and in a way that would make them efficient against all five .

US medical giant Johnson & Johnson is separately developing an experimental vaccine against two Ebola .

Delgado said researchers hope to get results from mouse experiments within a year.

The Ebola epidemic caused alarm in Spain in 2014 when a nursing assistant, Teresa Romero, became the first person infected outside Africa.

She caught the disease while tending to a Spanish missionary repatriated from Sierra Leone, who died in Spain in September that year.

Explore further: New Ebola vaccine faces key test

Related Stories

New Ebola vaccine faces key test

May 18, 2018
The experimental Ebola vaccine dubbed rVSV-ZEBOV has shown promising signs that it can contain the spread of the prolific killer virus.

DR Congo reports four more Ebola cases

May 10, 2018
Four more cases of Ebola have been detected in northwest Democratic Republic of Congo, doctors said Thursday, two days after DRC reported a fresh outbreak of the disease.

DR Congo authorises trial of experimental Ebola vaccine

May 29, 2017
The Democratic Republic of Congo has approved using an experimental Ebola vaccine to combat an outbreak of the virus in the northeast, the government said Monday.

Ebola death toll close to 3,900: WHO

October 8, 2014
The death toll in the world's worst-ever Ebola epidemic has edged closer to 3,900, with the virus killing nearly half of the more than 8,000 people infected, UN figures showed Wednesday.

Spain officially free of Ebola (Update)

November 29, 2014
The World Health Organization on Tuesday declared Spain free of Ebola after going a month and a half with no new cases since an infected nurse successfully beat the disease.

Recommended for you

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

Maternally acquired Zika immunity can increase dengue disease severity in mouse pups

November 14, 2018
To say that the immune system is complex is an understatement: an immune response protective in one context can turn deadly over time, as evidenced by numerous epidemiological studies on dengue infection, spanning multiple ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.